- Home
- LTGO vs AIIR Comparison
LTGO vs AIIR Comparison
Compare LTGO & AIIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LTGO | AIIR |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | United States | United Arab Emirates |
| Employees | N/A | N/A |
| Industry | | Tobacco |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2026 | 2025 |
Fundamental Metrics
Financial Performance| Metric | LTGO | AIIR |
|---|---|---|
| Price | $14.08 | $7.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $52.25 | $10.52 |
| AVG Volume (30 Days) | ★ 359.2K | 38.5K |
| Earning Date | 11-19-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.60 | $5.29 |
| 52 Week High | $25.93 | $8.97 |
Technical Indicators
Market Signals| Indicator | LTGO | AIIR |
|---|---|---|
| Relative Strength Index (RSI) | 31.16 | 47.82 |
| Support Level | N/A | $6.62 |
| Resistance Level | $20.49 | $7.38 |
| Average True Range (ATR) | 1.23 | 0.69 |
| MACD | -0.21 | -0.04 |
| Stochastic Oscillator | 1.69 | 36.22 |
Price Performance
Historical ComparisonAbout LTGO Latigo Biotherapeutics Inc. Common Stock
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
About AIIR Air Global PLC Ordinary Shares
AIR Global PLC operates in the social inhalation products sector and has operations across multiple international markets. Its portfolio includes businesses and products related to shisha and hookah, including flavored shisha molasses, hookah and shisha e-commerce platforms, and charcoal-free shisha devices. The company also conducts product research and testing in partnership with independent laboratories to support the development of inhalation-related products and technologies.